Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport for Upper Limb Spasticity in Post-Stroke Patients
NCT00216411Phase 4Completed
- Sponsor
- Ipsen
- Start
- Nov 2004
- Primary completion
- Jul 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of abobotulinumtoxinA in Spasticity, sponsored by Ipsen. Started Nov 2004; status: completed.
02
Drugs
abobotulinumtoxinA
03
Conditions
Spasticity
Beyond the preview
Go deeper on NCT00216411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216411.